Cell line · CVCL_0556
T98G
Cancer cell line, Homo sapiens. Glioblastoma. 102 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. T98G. Cell lines, record CVCL_0556. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0556
On this page
Cell line
As Cellosaurus gives it.
- Name
- T98G
- Accession
- CVCL_0556
- RRID
- RRID:CVCL_0556
- Synonyms
- T 98 G, T-98G, T98 G, T98-G
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 61Y
- Category
- Cancer cell line
- Diseases
- Glioblastoma (NCIt C3058); Glioblastoma (ORDO Orphanet_360)
- Derived from
- Brain (in situ)
- Parent
- T98 (CVCL_B368)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers102
2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Low-Density Lipoprotein Receptor-Targeted Biomimetic Nanoplatform Suppresses Glioblastoma Stemness and Remodels Antitumor Immunity via Dual Metabolic Disruption. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CCND1 Stability Regulated by USP7 Deubiquitination Controls Glioma Radioresistance via Ferroptosis. | Anal Cell Pathol (Amst) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacological Blockade of NMUR2 Suppresses Glioma Growth by Inhibiting STAT5-Mediated Transcription of Cell Cycle-associated Genes. | Int J Biol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Framework for evaluating in vitro vasculogenic mimicry using structural and metabolic parameters. | Cell Rep Methods | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TAF15-mediated m5C modification of MTHFD2 RNA reveals a novel therapeutic target for IDH mutant gliomas. | Biomark Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CUDC-907 inhibits glioblastoma and enhances glioblastoma sensitivity to temozolomide by inhibiting DNA damage repair. | Genes Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| B7 homolog 3-targeted CAR-T cells secreting EGFR T-cell engagers for improved control of glioblastoma progression. | Mol Biomed | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose-driven glioblastoma. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NFYC upregulates KLF1 expression and activate LDHA to drive glycolysis and tumor growth in glioblastoma cells. | Front Cell Dev Biol | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 102
See all 102 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | T98 | CVCL_B368 | Cell lines | |
| Derived from it | Ubigene T98G MCOLN1 KO | CVCL_E1CJ | Cell lines | |
| Derived from it | Ubigene T98G TPCN2 KO | CVCL_E1CK | Cell lines |
Cell banks10
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1690 | ATCC | |
| BCRJ | 0406 | BCRJ | |
| CLS | 305030 | CLS | |
| ECACC | 92090213 | ECACC | |
| IZSLER | BS TCL 63 | Cellosaurus | |
| JCRB | IFO50303 | JCRB | |
| JCRB | JCRB9041 | JCRB | |
| KCLB | 21690 | KCLB | |
| RCB | RCB1954 | RCB | |
| TKG | TKG 0471 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0556
GET https://conductscience.org/api/cell-lines/v1/CVCL_0556/papers?page=2